Insider · CIK 0001438226

SCHULMAN AMY W

Reports to the SEC for 14 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001438226

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-20	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	Director	AAward	+838 sh	—	—	24,049
2026-05-20	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+1,802 sh	—	—	1,802
2026-05-13	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+11.3K sh	$70.20	+$790K	23,211
2026-05-13	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.3K sh	—	—	0
2026-05-13	ELVElevance Health, Inc.A Award	Director	AAward	+563 sh	—	—	781
2026-03-12	ELVElevance Health, Inc.S Sale	Director	SSale	−26 sh	$287.50	−$7,475	218
2026-02-02	ELVElevance Health, Inc.A Award	Director	AAward	+218 sh	—	—	218
2025-06-11	GUTSFRACTYL HEALTH, INC. · Stock OptionA Award	Director	AAward	+22.5K sh	—	—	22,500
2025-05-08	ALNYALNYLAM PHARMACEUTICALS, INC.A Award	Director	AAward	+775 sh	—	—	11,961
2025-05-08	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+1,558 sh	—	—	1,558
2025-03-13	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,750 sh	$131.21	+$361K	11,186
2025-03-13	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,750 sh	—	—	0
2025-03-13	GUTSFRACTYL HEALTH, INC.P Purchase	Director	PPurchase	+8,550 sh	$1.17	+$9,964.17	8,550
2024-06-25	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+8,500 sh	$131.21	+$1.12M	16,936
2024-06-25	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−8,500 sh	$240.00	−$2.04M	8,436
2024-06-25	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,500 sh	—	—	2,750
2024-05-29	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$66.83	+$2M	30,136
2024-05-29	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−10.1K sh	$148.21	−$1.5M	20,015
2024-05-29	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−11.5K sh	$148.93	−$1.72M	8,499
2024-05-29	ALNYALNYLAM PHARMACEUTICALS, INC.S Sale	Director	SSale	−63 sh	$149.76	−$9,434.88	8,436
2024-05-29	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2024-05-16	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+5,228 sh	—	—	5,228
2024-02-01	GUTSFRACTYL HEALTH, INC. · Stock OptionA Award	Director	AAward	+45K sh	—	—	45,000
2023-06-14	SQZ Biotechnologies CoStock OptionA Award	Director, 10% Owner	AAward	+39.9K sh	—	—	39,875
2023-05-18	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+3,454 sh	—	—	3,454
2023-02-23	ALNYALNYLAM PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+136 sh	—	—	136
2023-02-23	ALNYALNYLAM PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−136 sh	—	—	0
2022-06-15	SQZ Biotechnologies CoStock OptionA Award	Director, 10% Owner	AAward	+20K sh	—	—	20,000
2022-05-18	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+5,153 sh	—	—	5,153
2022-02-23	ALNYALNYLAM PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Director	AAward	+136 sh	—	—	136
2021-12-22	SQZ Biotechnologies CoM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+10.1K sh	$2.02	+$20.4K	200,775
2021-12-22	SQZ Biotechnologies CoM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+7,458 sh	$4.59	+$34.2K	208,233
2021-12-22	SQZ Biotechnologies CoM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+6,581 sh	$4.59	+$30.2K	214,814
2021-12-22	SQZ Biotechnologies CoStock OptionM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−10.1K sh	—	—	439
2021-12-22	SQZ Biotechnologies CoStock OptionM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−7,458 sh	—	—	3,072
2021-12-22	SQZ Biotechnologies CoStock OptionM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−6,581 sh	—	—	3,949
2021-12-13	SQZ Biotechnologies CoP Purchase	Director, 10% Owner	PPurchase	+1,850 sh	$10.88	+$20.1K	1,850
2021-12-13	SQZ Biotechnologies CoP Purchase	Director, 10% Owner	PPurchase	+1,850 sh	$10.94	+$20.2K	1,850
2021-10-27	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+1,814 sh	—	—	1,814
2021-07-15	ALNYALNYLAM PHARMACEUTICALS, INC. · Stock Option (right to buy)A Award	Director	AAward	+4,032 sh	—	—	4,032
2021-06-15	SQZ Biotechnologies CoStock OptionA Award	Director, 10% Owner	AAward	+10.5K sh	—	—	10,500
2021-04-13	Hudson Executive Investment Corp. IIClass B Common StockP Purchase	Director	PPurchase	+20K sh	$0.00	+$58	20,000
2020-11-03	SQZ Biotechnologies CoC Conversion	Director, 10% Owner	CConversion	+22.2K sh	—	—	190,684
2020-11-03	SQZ Biotechnologies CoC Conversion	Director, 10% Owner	CConversion	+162K sh	—	—	161,994
2020-11-03	SQZ Biotechnologies CoC Conversion	Director, 10% Owner	CConversion	+2.32M sh	—	—	2,315,652
2020-11-03	SQZ Biotechnologies CoC Conversion	Director, 10% Owner	CConversion	+276K sh	—	—	275,860
2020-11-03	SQZ Biotechnologies CoP Purchase	Director, 10% Owner	PPurchase	+16.3K sh	$16.00	+$262K	178,340
2020-11-03	SQZ Biotechnologies CoP Purchase	Director, 10% Owner	PPurchase	+234K sh	$16.00	+$3.74M	2,549,306
2020-11-03	SQZ Biotechnologies CoSeries A Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−28.9K sh	—	—	0
2020-11-03	SQZ Biotechnologies CoSeries A Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−413K sh	—	—	0

Recent filings

Accepted (ET)
May 224
SCHULMAN AMY W0001178670-26-000041
SEC(opens sec.gov)
May 154
SCHULMAN AMY W0001438226-26-000009
SEC(opens sec.gov)
May 144
SCHULMAN AMY W0001178670-26-000017
SEC(opens sec.gov)
Mar 234
SCHULMAN AMY W0001438226-26-000007
SEC(opens sec.gov)
Feb 34
SCHULMAN AMY W0001438226-26-000005
SEC(opens sec.gov)
Jun 134
SCHULMAN AMY W0000950170-25-086148
SEC(opens sec.gov)
May 124
SCHULMAN AMY W0001735276-25-000061
SEC(opens sec.gov)
Mar 174
SCHULMAN AMY W0000950170-25-040466
SEC(opens sec.gov)
Mar 144
SCHULMAN AMY W0001735276-25-000037
SEC(opens sec.gov)
Jun 274
SCHULMAN AMY W0001735276-24-000072
SEC(opens sec.gov)
May 314
SCHULMAN AMY W0001735276-24-000058
SEC(opens sec.gov)

Companies

Address

CAMBRIDGE, MA, 02142